Erratum to: Which is the best aromatase inhibitor for postmenopausal breast cancer?

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2001年 / 17卷 / 6期
关键词：
D O I：
10.2165/00042310-200117060-00007
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 15
相关论文
共 50 条
  • [31] Synchronous presentation of breast cancer and hepatocellular carcinoma in a postmenopausal woman: Dual action of aromatase inhibitor on breast and hepatic cancer cells?
    Dede, D. S.
    Altundag, K.
    JOURNAL OF BUON, 2011, 16 (04): : 782 - 782
  • [32] Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 47 - 48
  • [33] Risks and benefits of aromatase inhibitors in postmenopausal breast cancer
    Michaud, LB
    Buzdar, AU
    DRUG SAFETY, 1999, 21 (04) : 297 - 309
  • [34] Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer
    Laura Boehnke Michaud
    Aman U. Buzdar
    Drug Safety, 1999, 21 : 297 - 309
  • [35] Aromatase inhibitor strategies in metastatic breast cancer
    McArthur, Heather L.
    Morris, Patrick G.
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2009, 1 : 67 - 72
  • [36] The aromatase inhibitor exemestane in the treatment of breast cancer
    Perez-Lopez, FR
    XI INTERNATIONAL CONGRESS OF SENOLOGY, 2000, : 67 - 75
  • [37] Safety of aromatase inhibitor therapy in breast cancer
    Lintermans, Anneleen
    Neven, Patrick
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1201 - 1211
  • [38] POTENCY AND SELECTIVITY OF THE NONSTEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
    DOWSETT, M
    STEIN, RC
    MEHTA, A
    COOMBES, RC
    CLINICAL ENDOCRINOLOGY, 1990, 32 (05) : 623 - 634
  • [39] Changes in endometrial thickness after conversion from tamoxifen to aromatase inhibitor in postmenopausal breast cancer patients
    Hwang, Kyuri
    Hwang, Ki Tae
    Kim, Yong Jin
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1452 - 1452
  • [40] CLINICAL AND ENDOCRINE EFFECTS OF THE ORAL AROMATASE INHIBITOR VOROZOLE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    JOHNSTON, SRD
    SMITH, IE
    DOODY, D
    JACOBS, S
    ROBERTSHAW, H
    DOWSETT, M
    CANCER RESEARCH, 1994, 54 (22) : 5875 - 5881
12345